Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (151-160 of 715) with videos related to

Pageof 72
Sort By:
Sangre|January 1, 1984
[Tissue plasminogen activator: mechanism of action and thrombolytic properties]J A Páramo, D Collen
Critical Reviews in Oncology/Hematology|January 1, 1986
The fibrinolytic system in manD Collen, H R Lijnen
Annals of the New York Academy of Sciences|January 1, 1989
Interaction of heparin with histidine-rich glycoproteinH R Lijnen, D Collen
European Heart Journal|November 1, 1985
Coronary thrombolysis with tissue-type plasminogen activator: an overviewF Van de Werf, D Collen
The American Journal of Cardiology|September 1, 1987
Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarctionD Collen, F Van de Werf
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Bovine Hageman factor: physicochemical properties and mechanism of activationA Molla, H Claeys, D Collen
Thrombosis Research|March 1, 1974
Letter: The fibrinogenolytic pathway of fibrinogen catabolism: a replyD Collen, N Semeraro, M Verstraete
Circulation|June 1, 1993
Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarctionD Collen, F Van de Werf
Biochimica Et Biophysica Acta|May 3, 1978
On the biological significance of the specific interaction between fibrin, plasminogen and antiplasminI Rákóczi, B Wiman, D Collen
Computers and Biomedical Research, an International Journal|December 1, 1971
Computer analysis of fibrinogen tracer dataR Piessens, D Collen, G Tytgat
Pageof 72

Showing results (151-160 of 715) with videos related to

Sort By:
Pageof 72
Sangre|January 1, 1984
[Tissue plasminogen activator: mechanism of action and thrombolytic properties]J A Páramo, D Collen
Critical Reviews in Oncology/Hematology|January 1, 1986
The fibrinolytic system in manD Collen, H R Lijnen
Annals of the New York Academy of Sciences|January 1, 1989
Interaction of heparin with histidine-rich glycoproteinH R Lijnen, D Collen
European Heart Journal|November 1, 1985
Coronary thrombolysis with tissue-type plasminogen activator: an overviewF Van de Werf, D Collen
The American Journal of Cardiology|September 1, 1987
Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarctionD Collen, F Van de Werf
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Proceedings: Bovine Hageman factor: physicochemical properties and mechanism of activationA Molla, H Claeys, D Collen
Thrombosis Research|March 1, 1974
Letter: The fibrinogenolytic pathway of fibrinogen catabolism: a replyD Collen, N Semeraro, M Verstraete
Circulation|June 1, 1993
Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarctionD Collen, F Van de Werf
Biochimica Et Biophysica Acta|May 3, 1978
On the biological significance of the specific interaction between fibrin, plasminogen and antiplasminI Rákóczi, B Wiman, D Collen
Computers and Biomedical Research, an International Journal|December 1, 1971
Computer analysis of fibrinogen tracer dataR Piessens, D Collen, G Tytgat
Pageof 72